Phase II of Efficacy and Toxicity of Maintenance Sub. Rituximab After Induction in Relapsed MCL and Non-eligible HSCT
Clinical trial NCT02267915 · UNKNOWN
Trial details
- NCT number
- NCT02267915
- Sponsor
- Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2019-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.